Qianjiang Yongan Pharmaceutical Co Ltd (002365) — Strategic Asset Allocation Index
Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a Strategic Asset Allocation Index of 46.9% as of September 2023. Strategic assets (PP&E of CN¥994.22 Million plus long-term investments of CN¥-) total CN¥994.22 Million, measured against net assets of CN¥2.12 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Qianjiang Yongan Pharmaceutical Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Qianjiang Yongan Pharmaceutical Co Ltd Strategic Asset Allocation Index (2009–2021)
This chart shows how Qianjiang Yongan Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 13 annual periods from 2009 to 2021. As of September 2023, the index stands at 46.9%, representing strategic assets of CN¥994.22 Million against net assets of CN¥2.12 Billion CNY. For live market cap and overall valuation, see 002365 market cap.
Annual Strategic Asset Allocation Index for Qianjiang Yongan Pharmaceutical Co Ltd (2009–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Qianjiang Yongan Pharmaceutical Co Ltd from 2009 to 2021, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 002365 net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 50.5% | CN¥988.96 Million | CN¥988.96 Million | CN¥- | CN¥1.96 Billion | ▼ -4.0 pp |
| 2020 | 54.6% | CN¥989.60 Million | CN¥989.60 Million | CN¥- | CN¥1.81 Billion | ▼ -6.4 pp |
| 2019 | 61.0% | CN¥1.01 Billion | CN¥1.01 Billion | CN¥- | CN¥1.66 Billion | ▼ -2.3 pp |
| 2018 | 63.2% | CN¥1.02 Billion | CN¥1.02 Billion | CN¥- | CN¥1.61 Billion | ▲ +13.8 pp |
| 2017 | 49.4% | CN¥664.53 Million | CN¥664.53 Million | CN¥- | CN¥1.34 Billion | ▲ +2.2 pp |
| 2016 | 47.2% | CN¥556.01 Million | CN¥556.01 Million | CN¥- | CN¥1.18 Billion | ▼ -6.0 pp |
| 2015 | 53.3% | CN¥596.22 Million | CN¥596.22 Million | CN¥- | CN¥1.12 Billion | ▼ -4.0 pp |
| 2014 | 57.2% | CN¥634.11 Million | CN¥634.11 Million | CN¥- | CN¥1.11 Billion | ▼ -6.8 pp |
| 2013 | 64.1% | CN¥691.74 Million | CN¥691.74 Million | CN¥- | CN¥1.08 Billion | ▲ +5.7 pp |
| 2012 | 58.4% | CN¥638.63 Million | CN¥638.63 Million | CN¥- | CN¥1.09 Billion | ▲ +14.0 pp |
| 2011 | 44.4% | CN¥468.67 Million | CN¥468.67 Million | CN¥- | CN¥1.06 Billion | ▲ +18.8 pp |
| 2010 | 25.6% | CN¥259.49 Million | CN¥259.49 Million | CN¥- | CN¥1.01 Billion | ▼ -42.9 pp |
| 2009 | 68.4% | CN¥221.84 Million | CN¥221.84 Million | CN¥- | CN¥324.17 Million | — |